Literature DB >> 8156600

A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits.

L Stephens1, A Smrcka, F T Cooke, T R Jackson, P C Sternweis, P T Hawkins.   

Abstract

Phosphoinositide 3 kinase (PI3K) is a key signaling enzyme implicated in receptor-stimulated mitogenesis, oxidative bursting in neutrophils, membrane ruffling, and glucose uptake. A PI3K has already been purified, cloned, and shown to be regulated by receptors that act via tyrosine kinase-dependent regulatory mechanisms. We report that an immunologically, pharmacologically, and chromatographically distinct form of PI3K activity present in neutrophils and U937 cells is specifically activated by G protein beta gamma subunits. This data suggests PI3Ks conform to the paradigm set by receptor regulation of phosphoinositidase Cs: different receptor transduction systems specifically regulate dedicated isoforms of effector protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8156600     DOI: 10.1016/0092-8674(94)90237-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  158 in total

1.  The EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner.

Authors:  C Gu; S Park
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  Mechanism of the regulation of type IB phosphoinositide 3OH-kinase byG-protein betagamma subunits.

Authors:  Sonja Krugmann; Matthew A Cooper; Dudley H Williams; Phillip T Hawkins; Len R Stephens
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

Review 3.  Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases.

Authors:  Adam P Curnock; Marisa K Logan; Stephen G Ward
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

4.  Mitogenic signalling by delta opioid receptors expressed in rat-1 fibroblasts involves activation of the p70s6k/p85s6k S6 kinase.

Authors:  M A Wilson; A R Burt; G Milligan; N G Anderson
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

5.  Pharmacological profile of phosphatidylinositol 3-kinases and related phosphatidylinositols mediating endothelin(A) receptor-operated native TRPC channels in rabbit coronary artery myocytes.

Authors:  J Shi; M Ju; W A Large; A P Albert
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

6.  Involvement of phosphoinositide 3-kinase and PTEN protein in mechanism of activation of TRPC6 protein in vascular smooth muscle cells.

Authors:  Michaël Monet; Nancy Francoeur; Guylain Boulay
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

Review 7.  G-protein signaling: back to the future.

Authors:  C R McCudden; M D Hains; R J Kimple; D P Siderovski; F S Willard
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

8.  Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway.

Authors:  J S Koh; W Lieberthal; S Heydrick; J S Levine
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

9.  Identification of a proline-rich sequence in the CD2 cytoplasmic domain critical for regulation of integrin-mediated adhesion and activation of phosphoinositide 3-kinase.

Authors:  W J Kivens; S W Hunt; J L Mobley; T Zell; C L Dell; B E Bierer; Y Shimizu
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Evidence for phosphatidylinositol 3-kinase as a regulator of endocytosis via activation of Rab5.

Authors:  G Li; C D'Souza-Schorey; M A Barbieri; R L Roberts; A Klippel; L T Williams; P D Stahl
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.